Patient-Derived Conditionally Reprogrammed Cells in Prostate Cancer Research is a research paper published in Cells (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01CA222148
National Institutes of Health
Grant: R33CA258016
National Institutes of Health
Grant: R01CA276474
National Institutes of Health
Grant: R01CA282282
National Institutes of Health
Grant: U01CA278927
National Institutes of Health
Grant: 5R01CA276474-02
Developing Functional Human Cell Models to Study Initiation and Progression of Prostate Cancer between AA and EA men
National Institutes of Health
Grant: 7R01CA222148-03
Conditionally Reprogrammed Cell Model for Castration-Resistant Prostate Cancer (CRPC)
National Institutes of Health
Grant: 5R33CA258016-02
Validating Urine Derived Cancer Cells (UDCC) -- Non-Invasive and Living Liquid Biopsies -- in Bladder Cancer Clinics
National Institutes of Health
Grant: 5R01CA282282-03
Decoding tumor metabolic and immunologic interactions driving different biological subtypes in patients with bladder cancer.
National Institutes of Health
Grant: 1U01CA278927-01
Evaluation of Pre-Analytical Factors of Urine Samples for Urine Cancer Cell Cultures (UCCC) --A Non-Invasive Biomarker – in Monitoring Response and Recurrence of Bladder Cancer
The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Grant: Start-up funding
NIH HHS
Grant: R01CA222148, R33CA258016, R01CA276474, U01CA278927
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals